查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1977737

全球新生兒篩檢設備市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Newborn Screening Instruments Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年，新生兒篩檢設備市場規模將從 2025 年的 10.1 億美元成長至 20.4 億美元，2026 年至 2034 年的複合年成長率為 8.19%。

全球新生兒篩檢設備市場正經歷強勁成長，這主要得益於人們對早期發現嬰幼兒疾病重要性的認知不斷提高。許多國家政府強制推行新生兒篩檢項目，以便及早發現代謝性疾病、遺傳性疾病和內分泌疾病。串聯式質譜質譜和分子診斷平台的技術進步提高了檢測的準確性和處理能力。發展中地區醫療基礎設施的不斷改善也進一步推動了市場成長。

成長要素包括新興經濟體出生率的上升以及先進篩檢方案的日益普及。醫院和診斷檢查室正在投資自動化、高通量系統以提高效率。對預防醫學和早期療育的日益重視也促進了需求成長。此外，政府資金和公共衛生政策正在推動綜合篩檢計畫的整合。

展望未來，就地檢驗的創新和基因篩檢能力的拓展有望推動市場發展。數位健康記錄的整合將簡化資料管理。新興市場正在建造新生兒醫療設施，這將創造巨大的成長機會。隨著早期診斷成為醫療重點，全球新生兒篩檢設備市場預計將持續擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球新生兒篩檢設備市場：依檢測類型分類

  • 市場分析、洞察與預測
  • 血斑測試
  • 聽力測試
  • 嚴重先天性心臟疾病（CCHD）篩檢
  • 代謝紊亂檢測

第5章：全球新生兒篩檢設備市場：依產品類型分類

  • 市場分析、洞察與預測
  • 質譜儀
  • 脈動式血氧監測儀系統
  • 聽力篩檢設備
  • 檢測試劑盒
  • DNA定序儀

第6章 全球新生兒篩檢設備市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • PerkinElmer Inc
    • Waters Corporation
    • Bio-Rad Laboratories Inc
    • Agilent Technologies Inc
    • Trivitron Healthcare
    • Natus Medical Incorporated
    • Zivak Technologies
    • Neogen Corporation
    • Medtronic
    • SCIEX（A Danaher Company）
簡介目錄
Product Code: VMR112113001

The Newborn Screening Instruments Market size is expected to reach USD 2.04 Billion in 2034 from USD 1.01 Billion (2025) growing at a CAGR of 8.19% during 2026-2034.

The Global Newborn Screening Instruments Market is witnessing strong growth driven by increasing awareness of early disease detection in infants. Governments across many countries have implemented mandatory newborn screening programs to identify metabolic, genetic, and endocrine disorders at an early stage. Technological advancements in tandem mass spectrometry and molecular diagnostic platforms are enhancing testing accuracy and throughput. Expanding healthcare infrastructure in developing regions is further supporting market expansion.

Key growth drivers include rising birth rates in emerging economies and growing adoption of advanced screening panels. Hospitals and diagnostic laboratories are investing in automated and high-throughput systems to improve efficiency. Increasing focus on preventive healthcare and early intervention is also strengthening demand. Additionally, government funding and public health initiatives are encouraging the integration of comprehensive screening programs.

Looking ahead, the market is expected to benefit from innovations in point-of-care testing and expanded genetic screening capabilities. Integration of digital health records will streamline data management. Emerging markets upgrading neonatal care facilities will create significant growth opportunities. As early diagnosis becomes a healthcare priority, the Global Newborn Screening Instruments Market is projected to experience sustained expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Type

  • Blood Spot Test
  • Hearing Test
  • Critical Congenital Heart Disease (CCHD) Test
  • Metabolic Disorder Test

By Product Type

  • Mass Spectrometers
  • Pulse Oximeters
  • Hearing Screening Devices
  • Assay Kits
  • DNA Sequencers

COMPANIES PROFILED

  • PerkinElmer Inc, Waters Corporation, BioRad Laboratories Inc, Agilent Technologies Inc, Trivitron Healthcare, Natus Medical Incorporated, Zivak Technologies, Neogen Corporation, Medtronic, SCIEX a Danaher Company
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEWBORN SCREENING INSTRUMENTS MARKET: BY TEST TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Test Type
  • 4.2. Blood Spot Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Hearing Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Critical Congenital Heart Disease (CCHD) Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Metabolic Disorder Test Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEWBORN SCREENING INSTRUMENTS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Product Type
  • 5.2. Mass Spectrometers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Pulse Oximeters Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Hearing Screening Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Assay Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. DNA Sequencers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEWBORN SCREENING INSTRUMENTS MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Test Type
    • 6.2.2 By Product Type
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Test Type
    • 6.3.2 By Product Type
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Test Type
    • 6.4.2 By Product Type
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Test Type
    • 6.5.2 By Product Type
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Test Type
    • 6.6.2 By Product Type
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL NEWBORN SCREENING INSTRUMENTS INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 PerkinElmer Inc
    • 8.2.2 Waters Corporation
    • 8.2.3 Bio-Rad Laboratories Inc
    • 8.2.4 Agilent Technologies Inc
    • 8.2.5 Trivitron Healthcare
    • 8.2.6 Natus Medical Incorporated
    • 8.2.7 Zivak Technologies
    • 8.2.8 Neogen Corporation
    • 8.2.9 Medtronic
    • 8.2.10 SCIEX (A Danaher Company)